Catherine Satzke

Mechanisms, organisms and markers of infection in pregnancy.

Identification of newly described Streptococcus pneumoniae serotype 6D by use of the Quellung reaction and PCR.

Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine.

Comparison of citrated human blood, citrated sheep blood, and defibrinated sheep blood Mueller-Hinton agar preparations for antimicrobial susceptibility testing of Streptococcus pneumoniae isolates.

Molecular epidemiology of Streptococcus pneumoniae serogroup 6 isolates from Fijian children, including newly identified serotypes 6C and 6D.

Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry.

Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children.

Serotype replacement after pneumococcal vaccination.

Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.

Production of latex agglutination reagents for pneumococcal serotyping.

Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination.

Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG.

In vitro growth of pneumococcal isolates representing 23 different serotypes.

Detection of group a streptococcal pharyngitis by quantitative PCR.

Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.

Silica desiccant packets for storage and transport of Streptococcus pneumoniae and other clinically relevant species.

Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.

Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.